Nine Years Seizure-Free and Still Expecting a No

You can usually get life insurance with epilepsy in the UK, and a long seizure-free interval is one of the most powerful things you can bring to the application. But it is assessed, not automatic. "Nine years seizure-free" is not a magic phrase that flips an insurer to standard terms on its own — it is a strong piece of evidence that an underwriter reads alongside several others. Knowing what those others are is the difference between expecting a flat no and understanding what your particular history is actually worth.

The frustration many people carry into this is that they have done everything right — years without a seizure, stable on their medication, discharged from regular neurology review — and still brace for a refusal because "epilepsy" sounds like a hard no. It generally is not. Many applications are accepted on standard or lightly rated terms. Where terms are added, it is because of the specific shape of the epilepsy, not the label.

So this page does the thing the word "seizure-free" alone cannot: it sets out what a UK underwriter actually weighs, why the same interval can produce different answers at different insurers, and the legal test an insurer has to meet before it can rely on your medical history at all.

The short answer: assessed, not automatic

Epilepsy is common and, for most people who have it, well controlled. Insurers know this, so the default posture is assessment rather than refusal. An underwriter's real concern is the small but genuine excess mortality attached to poorly controlled epilepsy — through sudden unexpected death in epilepsy, and through injury or drowning during a seizure. Those risks fall sharply as seizures come under control and stay away, which is precisely why a long seizure-free interval carries so much weight.

That framing should reset the question in your head. It is not "will they cover someone with epilepsy?" but "what does my particular epilepsy, controlled the way it is, look like to a risk assessor?" A person with focal seizures fully controlled for years on a single medicine, driving again and off neurology's books, presents very differently from someone with frequent generalised seizures despite treatment. The word covers both, and the underwriting does not.

The four things an underwriter actually weighs

Strip away the anxiety and the assessment comes down to a handful of factors, each of which you can find in your own records before you apply.

• Seizure type. Generalised tonic-clonic seizures, focal seizures, absence seizures and seizures that occur only in sleep carry different risk profiles. The type shapes the questions and the terms.
• Interval since the last seizure. How long you have gone without one, documented, is usually the single most influential factor. A recent seizure weighs heavily; a long, clean interval weighs strongly in your favour.
• Medication. Whether you take one medicine or several, at what dose, and whether it has been stable or recently changed. This is a marker of how settled your control is, not a black mark.
• Cause and stability. Whether an underlying cause was found — a structural change, a past head injury, a genetic basis, or none identified — and whether your control is stable and monitored, or still being adjusted.

These factors do not sit in separate boxes; an underwriter reads them together. Seizures that only ever happen in sleep, for instance, tend to be viewed more favourably than daytime tonic-clonic seizures, because the risk of injury from a fall or an accident is lower — and a documented pattern of that kind, held for a long time on unchanged medication, is a genuinely strong file. Equally, a seizure with a clear one-off provocation behind it reads differently from an unprovoked seizure that came without warning. The point is that two people who both write "epilepsy, well controlled" on the form can hand an underwriter very different pictures once these details are filled in, and it is the details, not the label, that set the terms.

Underwriters also ask whether you currently hold a driving licence, because the DVLA only relicenses after a defined seizure-free period, so a returned licence is external corroboration that your control has held. It is not the deciding factor, but it is a useful, independent signal alongside your own account. If you are still within a DVLA seizure-free waiting period, or have surrendered your licence, that is not a bar to applying — it simply means one of the corroborating signals is not yet available, and the interval since your last seizure carries the weight instead.

Why a long seizure-free interval is worth so much

If there is one thing to take from this page, it is that time without a seizure does most of the work. It is the factor an underwriter can lean on hardest, because it is objective, documented, and directly connected to the risks they care about. A long interval on stable medication, with neurology review settled or discharged, is close to the strongest position an applicant with epilepsy can be in.

But "seizure-free" is not a single thing, and this is where people are caught out. Insurers set their own thresholds for what a given interval is worth, and they differ. The same nine years, on the same medication, can produce standard terms at one insurer and a modest loading at another, simply because their underwriting appetites are calibrated differently. A single disappointing decision is therefore not a verdict from the market — it is one desk's view. The same "one insurer is not the market" logic that applies to weight and other rated factors applies here; the routes open when one insurer says no are set out in what is left above every insurer's BMI ceiling, and the principle transfers directly.

A long interval helps, but it does not erase the history, and an underwriter will still ask about seizure type, cause and medication. The interval reshapes the decision; it does not bypass the assessment.

Medication is evidence of control, not a penalty

People on anti-seizure medication often assume it counts against them — that being unmedicated would look better. Underwriting works the other way round. Medication that is keeping you seizure-free is evidence that your condition is identified, treated and stable. What an underwriter is wary of is instability: a recent change of medicine, a dose still being titrated, or seizures continuing despite treatment.

Broadly, being controlled on a single medicine tends to read more favourably than needing several to achieve the same control, and a long stretch on an unchanged regime reads more favourably than a recent switch. If your treatment has just changed, an insurer may prefer to see it settle before offering its best terms — a postponement here is about waiting for stability, not a judgement that you are uninsurable.

One point specific to cause. Where epilepsy has been linked to a genetic variant, the industry framework on genetics limits what an insurer may ask for: a predictive genetic result generally cannot be required, a distinction we explain in what replaced the genetic testing moratorium in 2018. And if you take a predictive genetic test after your cover has already begun, it cannot be used against that policy at all, as set out in a genetic test taken after the policy started. Your diagnosed epilepsy, your seizures and your medication remain ordinary medical information and are assessed as such; a predictive gene result is treated differently.

The test an insurer must meet, and your right to ask

An insurer cannot simply decide epilepsy is too much trouble. Where a policy takes a disability into account, the law requires the decision to rest on real evidence. Under the Equality Act 2010, an insurer may treat a disability differently only where it relies on information relevant to the risk, from a source it is reasonable to rely on — such as recognised medical or actuarial data, or your own medical records. A decision plucked from assumption rather than evidence is not something the Act permits.

That gives you a concrete right: to ask the insurer what information its decision relied on. If you are rated or declined, ask, in writing, what evidence was used and from what source. A well-supported decision will name it; a poorly supported one may not survive the question. To assess the case at all the insurer will usually, with your written consent, ask your GP or neurologist for a report — a step that sometimes ends in a refusal, and one worth understanding in advance through the insurer wrote to my GP and then said no.

If you are rated or declined

A loading or a refusal from one insurer is a starting point, not a conclusion. Three things are worth doing.

Find out exactly what the decision was — a decline, or a postponement to a future date — and on what evidence, using the right to ask set out above. Gather your neurologist's letters, your seizure history and your medication record, because a well-evidenced application presented properly tends to fare better than a bare form. And check any cover you already hold: an employer's death in service scheme normally provides a lump sum without individual medical underwriting up to a set limit, which means conditions that complicate an individual application — epilepsy, or something like an HIV diagnosis after a policy has started — often sit inside group cover with no underwriting question at all.

When you do apply again, an FCA-authorised broker who understands which insurers take which risks can place the case where it is most likely to succeed rather than firing it at the first name you find. If you want to begin that comparison, you can get life insurance quotes and let a broker match your history to the insurers whose thresholds suit it.

Scotland and Northern Ireland

How an underwriter weighs epilepsy — seizure type, interval, medication, stability — is the same across the UK, and the DVLA rules on relicensing after a seizure-free period apply throughout Great Britain, with Northern Ireland operating an equivalent driving-licence regime.

The one difference worth naming is the discrimination law behind your right to a properly evidenced decision. The Equality Act 2010 covers England, Wales and Scotland. Northern Ireland is not covered by that Act; disability discrimination there rests on the Disability Discrimination Act 1995. The underlying protection — that an insurer must base a disability-related decision on relevant, reliable information rather than assumption — runs through both, but the statute you would point to differs. You can read the rest of this topic in our hub on getting cover with a history, a condition or a job.

Frequently asked questions

Can you get life insurance with epilepsy?

Yes, and many applications are accepted on standard or lightly rated terms. Underwriters look at the type of seizures, how long since the last one, how many medicines you take, whether control is stable, whether an underlying cause was found, and whether you currently drive. An outright decline is the exception rather than the rule.

Does a long seizure-free period help?

Usually, and substantially. A long, documented interval on stable medication is one of the strongest factors in your favour, because it speaks directly to the risks an underwriter cares about. Insurers set their own thresholds, so the same interval can produce different terms at different insurers, and it helps to have your neurologist's letters available.

Can an insurer refuse me because of epilepsy?

It can decline, but the Equality Act 2010 allows disability to be taken into account in insurance only where the insurer relies on information relevant to the risk, from a source it is reasonable to rely on. You are entitled to ask what information was used. In Northern Ireland the equivalent protection comes from the Disability Discrimination Act 1995.